131 related articles for article (PubMed ID: 3593991)
1. Antiestrogen binding sites in microsomal fractions of malignant and nonmalignant human breast tissues.
Mehta RR; DasGupta TK
Breast Cancer Res Treat; 1987; 9(1):61-7. PubMed ID: 3593991
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and antiestrogen binding sites in desmoid tumors.
Lim CL; Walker MJ; Mehta RR; Das Gupta TK
Eur J Cancer Clin Oncol; 1986 May; 22(5):583-7. PubMed ID: 3770030
[TBL] [Abstract][Full Text] [Related]
3. Characterization of estrogen and antiestrogen binding to the cytosol and microsomes of breast tumors.
Lopes MC; Tavares MC; Vale MG; Carvalho AP
J Steroid Biochem Mol Biol; 1991 Sep; 39(3):343-52. PubMed ID: 1911424
[TBL] [Abstract][Full Text] [Related]
4. Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer.
Gulino A; Vacca A; Modesti A; Screpanti I; Farina A; Frati L
Biochem Pharmacol; 1986 Nov; 35(21):3863-70. PubMed ID: 3778510
[TBL] [Abstract][Full Text] [Related]
5. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
[TBL] [Abstract][Full Text] [Related]
6. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
Watts CK; Sutherland RL
Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
[TBL] [Abstract][Full Text] [Related]
7. Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites.
Katzenellenbogen BS; Miller MA; Mullick A; Sheen YY
Breast Cancer Res Treat; 1985; 5(3):231-43. PubMed ID: 4027393
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells.
Burke PJ; Kalet BT; Koch TH
J Med Chem; 2004 Dec; 47(26):6509-18. PubMed ID: 15588086
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and progesterone receptors in breast carcinoma and in nonmalignant breast tissue.
Gion M; Mione R; Dittadi R; Griggio L; Munegato G; Valescchi M; Del Maschio O; Fasan S; Bruscagnin G
Tumori; 1985 Oct; 71(5):477-81. PubMed ID: 4060249
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of the microsomal tamoxifen binding site.
Kedjouar B; de Médina P; Oulad-Abdelghani M; Payré B; Silvente-Poirot S; Favre G; Faye JC; Poirot M
J Biol Chem; 2004 Aug; 279(32):34048-61. PubMed ID: 15175332
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting anti-estrogen binding site concentration in rat liver.
How BE; Hwang PL
Proc Soc Exp Biol Med; 1991 Jul; 197(3):279-84. PubMed ID: 2068121
[TBL] [Abstract][Full Text] [Related]
12. Antiestrogen binding sites in human breast cancer biopsies. Measurement ligand-specificity and affinity, and correlation to estrogen and progesterone receptors.
Fernö M; Borg A
Anticancer Res; 1985; 5(3):307-12. PubMed ID: 4015045
[TBL] [Abstract][Full Text] [Related]
13. High affinity specific antiestrogen binding sites are concentrated in rough microsomal membranes of rat liver.
Watts CK; Sutherland RL
Biochem Biophys Res Commun; 1984 Apr; 120(1):109-15. PubMed ID: 6712683
[TBL] [Abstract][Full Text] [Related]
14. Microsomal binding sites for antioestrogens in rat liver. Properties and detergent solubilization.
Watts CK; Sutherland RL
Biochem J; 1986 Jun; 236(3):903-11. PubMed ID: 3790095
[TBL] [Abstract][Full Text] [Related]
15. Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism.
Payré B; de Medina P; Boubekeur N; Mhamdi L; Bertrand-Michel J; Tercé F; Fourquaux I; Goudounèche D; Record M; Poirot M; Silvente-Poirot S
Mol Cancer Ther; 2008 Dec; 7(12):3707-18. PubMed ID: 19074846
[TBL] [Abstract][Full Text] [Related]
16. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor.
Sheen YY; Simpson DM; Katzenellenbogen BS
Endocrinology; 1985 Aug; 117(2):561-4. PubMed ID: 4017947
[TBL] [Abstract][Full Text] [Related]
18. Cytosol and nuclear estrogen receptors (occupied and unoccupied sites) and progesterone receptors in human breast cancer.
Sumida C; Magdelenat H; Pasqualini JR
Breast Cancer Res Treat; 1985; 5(2):165-9. PubMed ID: 4016282
[TBL] [Abstract][Full Text] [Related]
19. International comparisons concerning breast cancer and steroid receptors.
Matsumoto K; Sakamoto G; Nomura Y
Anticancer Res; 1986; 6(4):621-4. PubMed ID: 3752942
[TBL] [Abstract][Full Text] [Related]
20. Relationship between estrogen receptors, 17 beta-hydroxysteroid dehydrogenase and estrogen content in human breast cancer.
Abul-Hajj YJ
Steroids; 1979 Aug; 34(2):217-25. PubMed ID: 494363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
